A Circulating Bioreactor Reprograms Cancer Cells Toward a More Mesenchymal Niche

Çalamak S., Ermis M., Sun H., Islam S., Sikora M., Nguyen M., ...More

Advanced Biosystems, vol.4, no.2, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.1002/adbi.201900139
  • Journal Name: Advanced Biosystems
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Keywords: bioreactors, circulating tumor cells, epithelial to mesenchymal transition, fluidics, programming, shear force, ADAPTIVE-RESPONSE GENE, TUMOR-CELLS, SHEAR-FLOW, TGF-BETA, IN-VIVO, ADHESION, MIGRATION, INVASION, MATRIX, CD44
  • Lokman Hekim University Affiliated: No


© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimCancer is a complex and heterogeneous disease, and cancer cells dynamically interact with the mechanical microenvironment such as hydrostatic pressure, fluid shear, and interstitial flow. These factors play an essential role in cell fate and circulating tumor cell heterogeneity, and can influence the cellular phenotype. In this study, a peristaltic continuous flow reactor is designed and applied to HCT-116 colorectal carcinoma cells to mimic the fluid dynamics of circulation. With this intervention, a CD44/CD24-cell subpopulation emerges, and 100 genes are significantly regulated. The expression of cells at 4 h in the flow reactor is very similar to TGF-ß treatment, which is an inducer of epithelial–mesenchymal transition. ATF3 and SERPINE1 are significantly upregulated in these groups, suggesting that the mesenchymal transition is induced through this signaling pathway. This flow reactor model is satisfactory on its own to reprogram colorectal cancer cells toward a more mesenchymal niche mimicking circulation of the blood.